Drug combination reduces colon cancer risk
(Reuters)
Reuters - Combining a low dose of a targeted
cancer-fighter with an anti-inflammatory drug reduces the risk
of recurring colorectal polyps, an early sign of colon cancer,
by as much as 95 percent, researchers said on Monday.
http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/nm/20080414/hl_nm/cancer_colon_prevention_dc